Health Canada clears Labopharm’s Oleptro

Labopharm (NASDAQ:DDSS; TSX:DDS) has received approval from Health Canada’s Therapeutic Products Directorate for Oleptro, a once-daily formulation of the antidepressant trazodone, for the symptomatic relief of major depressive disorder in adults. “Our plan is to commercialize Oleptro in Canada with a marketing partner and we are advancing discussions towards this end, while at the same [...]

Angelini Labopharm joint venture launches Oleptro

Labopharm (TSX:DDS; NASDAQ:DDSS) and its joint venture partner Gruppo Angelini have launched Oleptro, an once-daily formulation of the antidepressant trazodone, in the U.S. “The commercialization strategy for Oleptro is based on extensive research into the physician, patient and payer audiences and employs a targeted, efficient sales effort that is designed to maximize the return on [...]

Labopharm amends loan accord with Hercules

Hercules Technology Growth Capital has agreed to extend both the period of interest-only payments and maturity date of a loan to Labopharm (TSX:DDS; NASDAQ:DDSS), which will provide Labopharm with $4.5 million in additional liquidity in 2010 and throughout 2011. Under the amended agreement, Hercules has extended the period for Labopharm to make interest-only payments on the [...]

Labopharm’s new antidepressant to be ‘game-changer’

It’s game on for Labopharm (TSX:DDS; NASDAQ:DDSS). By February 11, the FDA is expected to approve the company’s antidepressant trazodone, a novel once-daily formulation that addresses many of the shortcomings of similar drugs on the market.  “I think it’s fair to say this drug could be a game-changer for us,” CEO James Howard-Tripp says in [...]

Labopharm’s trazodone drug in peer-reviewed medical journal

An article in the October issue of CNS Spectrums, an international journal of neuropsychiatric medicine, cites the potential benefits of Labopharm’s new trazodone formulation, which contains its Contramid technology to control the release of active ingredients to improve drug delivery. “Although trazodone has traditionally been used as a low dose hypnotic, a new controlled release [...]